December Newsmakers

Cancer Is (ESPN)
Features Michael B. Kastan, MD, PhD; Daniel George, MD; Katy Peters, MD; and Kris Wood, PhD.

Why Women With Early Signs of Breast Cancer Are Doing Nothing About It (The Daily Beast) 
Features E. Shelley Hwang, MD

Can “RoboSperm” Really Be Used to Fight Cervical Cancer? (Futurism)

NCCN creates new resource for patients who develop AIDS-related Kaposi sarcoma (NCCN)
Features Gita Suneja, MD 

Balancing Evidence, Value for Broadening Use of PARP Inhibitors (MEDPAGE TODAY)
Features Andrew Berchuck, MD

ASCO 2017: Interpreting Biomarkers and Trial Outcomes: How Confident Are We? (UroToday)
Features Susan Halabi, PhD, and Andrew Armstrong, MD

Nothing for granted: Bozeman man a pioneer on the frontier of fighting cancer (Bozeman Daily Chronicle)
Features Henry Friedman, MD

Stomping The Stigma Of Lung Cancer (Cure Today) 
Features lung cancer survivor Taylor Bell Duck 

Blackwell Inaugurated as VP of Early Phase Development and Immuno-Oncology at Lilly (Targeted Oncology)

Kimberly Blackwell, MD, to become Vice President of Early Phase Development and Immuno-oncology at Lilly Oncology (Eli Lilly and Company)

New Reads This Fall From Duke Faculty (Duke Today)
Features Andrew Berchuck, MD; Gretchen Kimmick, MD; John Sampson, MD, PhD; Vidya Chandramohan, PhD; Darell Bigner, MD, PhD  

New two-pronged therapy could prolong survival time in glioblastoma patients (The Chronicle)
Features Elizabeth Reap, PhD

WATCH: Dr. Armstrong on Sipuleucel-T in Prostate Cancer (OncLive)
Features Andrew Armstrong, MD, MSc

WATCH: Dr. Inman on Immunotherapy Combinations in Bladder Cancer (OncLive)
Features Brant Inman, MD, MA

WATCH: Dr. Berry on Novel Imaging Techniques for Prostate Cancer (OncLive)
Features William R. Berry, MD

WATCH: Dr. Harrison on Choosing Frontline Treatment for RCC (OncLive)
Features Michael R. Harrison, MD

WATCH: Dr. Zhang Discusses the KEYNOTE-564 Trial in RCC (OncLive)
Features Tian Zhang, MD

WATCH: Dr. Zhang on the ARCHES Trial in Prostate Cancer (OncLive)
Features Tian Zhang, MD

Pembrolizumab Investigated as Adjuvant RCC Therapy (OncLive)
Features Tian Zhang, MD

WATCH: Ask Dr. Mask: How do I know I don't have cancer? (WRAL)
Features Neeraj Agrawal, MD

WATCH: Thomas W. LeBlanc, MD, on Hematologic Malignancies: The Case for Palliative Care (JNCCN)
Features Thomas LeBlanc, MD

Existing cancer medication offers potential to treat Huntington's disease (Medical Xpress)
Features Al La Spada, MD, PhD

Duke Research Accepted for Presentation at SGO Annual Meeting (Duke Obstetrics & Gynecology)
Features Angeles Secord, MD, MHSc and Lauren Cobb, MD

Three Faculty Elected Fellows of AAAS (Duke Today)
Features David Kirsch, MD, PhD

Five Recognized With Inaugural Palliative Care Award (Duke Today)
Features Hope Uronis, MD 

Fighting Neuroblastoma Like a Superhero (Duke Health News)
Features Timothy Driscoll, MD   

Cells Bulge to Squeeze Through Barriers (Duke Today)
Features David Sherwood, PhD

WATCH: Duke Raleigh Hospital's David Zaas reflects on cancer treatment, support of Duke community (Duke Health)
Features (Duke Raleigh president) David Zaas, MD, MBA  

PAPERS: 

Maintenance Poly (ADP-ribose) Polymerase Inhibitor Therapy for Ovarian Cancer: Precision Oncology or One Size Fits All?; Journal of Clinical Oncology, published online before print, October 26, 2017. Andrew Berchuck, MD; Angeles Alvarez Secord, MD; Haley A. Moss, MD, MBA; and Laura J. Havrilesky, MD, MHSc.

Cell Invasion in Vivo Via Rapid Exocytosis of a Transient Lysosome-Derived Membrane Domain; Developmental Cell, Nov. 20, 2017. Kaleb Naegeli, Eric Hastie, Aastha Garde, Zheng Wang, Daniel Keeley, Kacy Gordon, Ariel Pani, Laura Kelley, Meghan Morrisey, Qiuyi Chi, Bob Goldstein and David Sherwood.

Out-of-Pocket Costs, Financial Distress, and Underinsurance in Cancer Care. JAMA Oncology. November 2017. Fumiko Chino, MD; Jeffrey M. Peppercorn, MD, MPH; Christel Rushing, MS; Arif H. Kamal, MD, MHS; Ivy Altomare, MD; Greg Samsa, PhD; S. Yousuf Zafar, MD, MHS